Professor John Perry
Microbiology & Virology Services
Tel: 0191 223 1226
Qualifications: MSc, Ph.D, CSci, FIBMS
John oversees research and development in Microbiology & Virology at the Newcastle upon Tyne Hospitals, where he has worked for over 30 years. He is an Honorary Senior Lecturer at Newcastle University and a visiting Professor at Northumbria University. He has published over 120 scientific papers and over 20 patents, mainly in the field of diagnostic Clinical Microbiology.
His research interests include the development and evaluation of new clinical diagnostics , with a special interest in the development of culture media , and the evaluation of novel antimicrobial agents. Much of this work has been performed in collaborative projects with industry and academia.
McDonnell, M.J., Jary, H.R., Perry, A., MacFarlane, J.G., Hester, K.L.M., Small, T., Molyneux, C., Perry, J.D., Walton, K.E. & De Soyza, A. (2015) Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respiratory Medicine 109, 716-726.
Preece, C., Perry, A., Gray, B., Kenna DT, Jones, A.L., Cummings, S.P., Robb, A., Thomas, M.F., Brodlie, M., O’Brien, C.J., Bourke, S.J. & Perry, J.D. (2015) A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis. Journal of Cystic Fibrosis. doi: 10.1016/j.jcf.2015.05.002
Sandoe, J., Barlow, G., Chambers, J., Gammage, M., Guleri, A., Howard, P., Olson, E., Perry, J.D., Prendergast, B., Spry, M., Steeds, R., Tayebjee, M. & Watkin, R. (2015) New guidelines for prevention and management of implantable cardiac electronic device-related infection. The Lancet 385(9984):2225-6.
Sandoe, J., Barlow, G., Chambers, J., Gammage, M., Guleri, A., Howard, P., Olson, E., Perry, J.D., Prendergast, B., Spry, M., Steeds, R., Tayebjee, M. & Watkin, R. (2015) Guidelines for the diagnosis, prevention and management of Implantable Cardiac Electronic Device infection. Journal of Antimicrobial Chemotherapy 70, 325-59.
Tariq, M.A., Everest, F.L.C., Cowley, L., De Soyza, A., Holt, G.S., Bridge, S.H., Perry, A., Perry, J.D. Bourke, S., Cummings, S., Lanyon, C.V., Barr, J.J. & Smith, D.L. (2015) A metagenomic approach to characterize temperate bacteriophage populations from cystic fibrosis and non-cystic fibrosis bronchiectasis patients. Frontiers in Microbiology. doi: 10.3389/fmicb.2015.00097
Zarakolu, P., Day, K.M., Sidjabat, H.E., Kamolvit, W., Lanyon, C.V., Cummings, S.P., Paterson, D.L., Akova, M. & Perry, J.D. (2015) Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey. European Journal of Clinical Microbiology and Infectious Diseases 34, 519-25.
Dean, J.R., Stanforth, S.P., Tait, E., Reed, S. & Perry J.D. (2015) Analysis of pathogenic bacteria using exogenous volatile organic compound metabolites and optical sensor detection. Royal Society of Chemistry Advances 5, 15494-15499
Kanagasundaram, N.S., Perry, J.D., Clark, R.A., Hoenich, N.A., Fraser, R.A., Walton, K.E. (2015) Fluids for continuous renal replacement therapy – an evaluation of microbial integrity. International Journal of Artificial Organs 38, 13-6